Skip to main content
. 2023 May 30;17(8):E228–E235. doi: 10.5489/cuaj.8229

Table 4.

Three-month postoperative functional outcomes

Preoperative (n=45) 3 months postoperative (n=45)

IPSS *
Mean (SD) 18.1/35 (7.6/35) 6.7/35 (4.3/35)
Median 19.0/35 6.0/35
Range (0/35–30/35) (0/35–18/35)
Change from baseline (SD) −11.3 (8.2)

IPSS quality of life *
Mean (SD) 4.5/6 (1.6/6) 1.7/6 (1.8/6)
Median 4.5/6 1.0/6
Range (0/6–6/6) (0/6–6/6)
Change from baseline (SD) −2.7 (2.3)

Postvoid residual volume (ml) *
Mean (SD) 219.1 (148.9) 75.0 (71.3)
Median 167.0 44.0
Range (60.0–600.0) (0–259.0)
Change from baseline (SD)* −177.4 (147.5)

Qmax (mL/second) **
Mean (SD) 4.1 (6.5) 19.8 (11.2)
Median 0.0 17.0
Range (0.0–36.0) (3.5–49.0)
Change from baseline (SD)* +16.0 (12.5)

Catheter or self-catheterization-dependent, n (%) 35 (67.3) 2 (3.8)
*

Only applies to patients non-catheter or self-catheterization-dependent.

**

Patients who were catheter or self-catheterization-dependent were considered to have a Qmax of 0.

IPSS: International Prostate Symptom Score; SD: standard deviation; Qmax: maximum urinary flow rate.